Carillon Tower Advisers’s Omnicell OMCL Stock Holding History

Carillon Tower Advisers’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$47M	Sell	391,747 -79,121	-17%	-$7.76M	0.29%	113
2020 Q3	$35.2M	Sell	470,868 -32,826	-7%	-$2.28M	0.47%	51
2020 Q2	$35.6M	Sell	503,694 -58,032	-10%	-$3.97M	0.27%	117
2020 Q1	$35.3M	Sell	561,726 -51,386	-8%	-$4.09M	0.35%	101
2019 Q4	$50.1M	Sell	613,112 -4,000	-0.6%	-$307K	0.33%	94
2019 Q3	$44.6M	Buy	617,112 +116,709	+23%	+$8.57M	0.31%	116
2019 Q2	$43M	Sell	500,403 -120,109	-19%	-$9.76M	0.3%	118
2019 Q1	$50.2M	Buy	620,512 +120,109	+24%	+$8.99M	0.35%	94
2018 Q4	$60.7M	Sell	500,403 -144,209	-22%	-$9.76M	0.51%	47
2018 Q3	$46.3M	Buy	644,612 +144,209	+29%	+$9.08M	0.33%	112
2018 Q2	$26.2M	Buy	500,403 +338,403	+209%	+$15.9M	0.21%	172
2018 Q1	$70.3M	Sell	162,000 -634,115	-80%	-$29.2M	0.55%	36
2017 Q4	$38.6K	Buy	+796,115	New	+$40.2M	0.41%	86

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Carillon Tower Advisers's OMCL Position: Q4 2020 in Review

Carillon Tower Advisers reduced its Omnicell (OMCL) stake by 17% in Q4 2020, selling an estimated $7.76M and leaving 391,747 shares worth $47M. The position accounts for 0.29% of the portfolio, ranked #113.

Carillon Tower Advisers first reported a position in OMCL in Q4 2017 and has held it in 13 quarters since. The position peaked at $70.3M in Q1 2018. 354 funds tracked by Wall St. Rank hold OMCL as of Q4 2020.

Carillon Tower Advisers held 391,747 shares of Omnicell worth $47M as of Q4 2020.
Carillon Tower Advisers sold 79,121 Omnicell shares in Q4 2020, an estimated $7.76M.
Omnicell made up 0.29% of Carillon Tower Advisers's portfolio in Q4 2020, its #113 holding.
Carillon Tower Advisers first reported a position in Omnicell in Q4 2017 and has held it in 13 quarters since.
Carillon Tower Advisers's Omnicell position peaked at $70.3M in Q1 2018.
354 funds tracked by Wall St. Rank held Omnicell as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.